Source:http://linkedlifedata.com/resource/pubmed/id/18186796
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2008-1-11
|
pubmed:abstractText |
CCL5/RANTES, a member of the C-C chemokine family, is a potent eosinophil, monocyte, basophile and lymphocyte chemo-attractant at the site of inflammation. Recent studies revealed that a functional mutation at the -403 position in the promoter may have significance for atopic dermatitis, bronchial asthma, sarcoidosis, rheumatoid arthritis and HIV infection, and others. Another polymorphism in the -28 position has been reported. Our objective was to investigate the possible influence of the CCL5/RANTES promoter polymorphisms in the different types of bronchial asthma. CCL5/RANTES genotyping was performed by polymerase chain reaction-restriction fragment-length polymorphism (PCR-RFLP) in 306 asthmatic patients with non-atopic (n = 145) and atopic (n = 161) asthma and 242 controls. The 81.9% of the atopic asthma patients for -403G/A had the G allele and the A allele frequency was 18%. Of the non-atopic asthma patients, the G allele frequency was 79.7% and the A allele was 20.3%. Concerning the -28C/G polymorphism, the frequency of the CCL5/RANTES -28G allele in our patients is 2.8%, which is similar to Spanish adult population. After comparing patients with asthma, atopic patients, non-atopic patients and control population, we found no significant deviation in the distribution of the alleles or genotypes of CCL5/RANTES promoter polymorphisms in any tested comparison. Therefore, human CCL5/RANTES gene promoter polymorphisms are not associated with the different types of bronchial asthma in Spanish population.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1744-313X
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
35
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
19-23
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:18186796-Adult,
pubmed-meshheading:18186796-Asthma,
pubmed-meshheading:18186796-Chemokine CCL5,
pubmed-meshheading:18186796-Female,
pubmed-meshheading:18186796-Genetic Predisposition to Disease,
pubmed-meshheading:18186796-Humans,
pubmed-meshheading:18186796-Male,
pubmed-meshheading:18186796-Polymorphism, Genetic,
pubmed-meshheading:18186796-Promoter Regions, Genetic,
pubmed-meshheading:18186796-Spain
|
pubmed:year |
2008
|
pubmed:articleTitle |
CCL5/RANTES chemokine gene promoter polymorphisms are not associated with atopic and nonatopic asthma in a Spanish population.
|
pubmed:affiliation |
Department of Immunology, University Hospital Virgen Arrixaca, Murcia, Spain. manuel.muro@carm.es
|
pubmed:publicationType |
Journal Article
|